Jeremy K. Hon

Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials

Pierre Major, Alain Lortholary, Jeremy K. Hon et al. · Journal of Clinical Oncology · 2001 · 857 citations

Medicine, Pharmacology, Pharmacotherapy +10

Weekly <i>nab</i>-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial

Mark A. Socinski, Igor Bondarenko, Nina Karaseva et al. · Journal of Clinical Oncology · 2012 · 754 citations · Full text

Medicine, Oncology, Pharmacology +14

Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures.

Nobuhiro Takahashi, Brian MacDonald, Jeremy K. Hon et al. · Journal of Clinical Investigation · 1986 · 121 citations · Full text

Medicine, Endocrinology, Bone Metabolism +11

Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer

Mark A. Socinski, Corey J. Langer, Isamu Okamoto et al. · Annals of Oncology · 2012 · 107 citations

Medicine, Oncology, Pharmacology +9

Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer

Mark A. Socinski, Isamu Okamoto, Jeremy K. Hon et al. · Annals of Oncology · 2013 · 66 citations

Medicine, Oncology, Pharmacology +10